Kansas Cannabis Laws

Kansas Cannabis Laws: Marijuana Prohibition, CBD Exceptions, and Legal Changes Over Time

Updated October 11, 2026.

Recreational marijuana remains illegal in Kansas, and the state has not established a comprehensive medical marijuana program. Kansas has made narrower changes involving possession penalties, cannabidiol, and industrial hemp.

Those exceptions do not authorize marijuana dispensaries, unrestricted THC products, or personal marijuana cultivation. Understanding Kansas law requires separating ordinary marijuana possession from compliant hemp products and the limited medical defense created by Claire and Lola’s Law.

Kansas Cannabis Laws at a Glance

Sources: possession statute, controlled-substance definitions, and current hemp licensing guidance.

The History of Cannabis Laws in Kansas

The Continuing Prohibition Framework

Kansas’s modern cannabis restrictions operate through its controlled-substances laws. They address possession, cultivation, distribution, and related conduct separately. Later reforms reduced certain penalties and created limited exceptions while leaving general marijuana prohibition in place.

This explains why a cannabis-related bill can change the law without legalizing marijuana. The activity authorized by the measure matters as much as its title.

2016: Possession Penalties Are Reduced

House Bill 2462 changed the penalties for first and second marijuana possession convictions. Effective July 1, 2016, the reform placed a first offense in the Class B misdemeanor category and a second qualifying offense in the Class A category.

The change reduced criminal exposure but did not make possession lawful or create a civil-only system. See HB 2462’s legislative history.

2018: Cannabidiol Is Excluded From the Marijuana Definition

Senate Bill 282 changed Kansas’s controlled-substance framework in 2018, including its treatment of cannabidiol. The legislation became effective May 24, 2018.

The CBD exclusion did not remove THC restrictions or authorize a medical marijuana marketplace. A product containing CBD and another controlled substance cannot rely solely on the cannabidiol exclusion.

Sources: SB 282 and current definitions.

2018–2021: Hemp Research Develops Into Commercial Production

Kansas initially allowed industrial hemp production through a research framework. Following federal hemp reform, it developed a commercial program with USDA approval in April 2020 and regulations effective January 8, 2021.

This created an agricultural opportunity with licensing, testing, and compliance requirements. It did not authorize growing marijuana or automatically make every hemp-derived consumer product lawful. See KDA’s commercial program announcement.

2019: Claire and Lola’s Law Takes Effect

Claire and Lola’s Law took effect July 1, 2019. It established a narrow framework for certain CBD treatment oils containing THC and associated protections for qualifying families.

The law uses a THC concentration of no more than 5 percent relative to the CBD concentration, verified by an independent laboratory. This is a ratio requirement, not permission for an oil containing 5 percent THC by total product weight.

For example, a preparation containing 10 percent CBD would have a corresponding THC ceiling of 0.5 percent under that ratio, assuming all other requirements are satisfied. Source: K.S.A. 65-6235.

2021: Total THC in Hemp Products Is Clarified

Changes to the hemp framework addressed the THC concentration in final hemp products. Attorney General Opinion 2021-4 subsequently explained that the 0.3 percent limit concerns total tetrahydrocannabinols, including delta-8 and delta-9.

The opinion did not declare every delta-8 product lawful. Its conclusion depended on industrial-hemp sourcing, the total THC ceiling, and whether the product itself belonged to a lawful category. See the official attorney general opinion.

2025–2026: Medical Legalization Proposals Do Not Become Law

Senate Bill 294 proposed a Kansas medical cannabis system covering cultivation, processing, distribution, sales, and patient use. The Legislature’s official record marks the measure as having died.

Its proposed patient protections and licensing provisions therefore did not establish an operational medical program. Kansas’s existing possession rules and narrow exceptions remain the relevant framework. See SB 294’s official status.

Marijuana Possession Penalties

Ordinary marijuana or prohibited THC possession is generally a Class B nonperson misdemeanor. One qualifying prior conviction can increase it to a Class A nonperson misdemeanor; two or more can produce a drug severity level 5 felony.

Qualifying records can include substantially similar offenses from other jurisdictions and certain municipal or county offenses. The precise record matters when determining an enhancement.

A Class B misdemeanor carries up to six months in county jail and a $1,000 fine. A Class A misdemeanor carries up to one year and a $2,500 fine. Felony sentences depend on Kansas sentencing rules and criminal history.

Sources: misdemeanor imprisonment limits and fine limits.

What the Limited Medical CBD Defense Requires

The defense applies to qualifying patients, or parents or guardians of qualifying minor children, who possess the specified preparation to treat a debilitating condition. The person must carry a letter from the diagnosing Kansas-licensed physician.

The letter must be on the physician’s letterhead, identify the patient and condition, be dated within the preceding fifteen months, and be shown to law enforcement on request. This is an affirmative defense to a specified possession prosecution, rather than a general medical marijuana card.

See K.S.A. 21-5706(d).

CBD and Hemp Product Restrictions

Kansas law distinguishes cannabidiol itself from THC-containing mixtures and qualifying industrial hemp products. Consumers should verify the entire formulation rather than assume that a “CBD,” “full spectrum,” or “hemp-derived” label establishes compliance.

The state also prohibits manufacturing, marketing, selling, or distributing specified hemp product forms, including hemp cigarettes, cigars, teas, certain smokeless products, and products for vaporizing devices. Separate restrictions address consumer sales of hemp buds and ground floral or leaf material.

The 0.3 percent hemp threshold is therefore only part of the legal analysis. Source: K.S.A. 2-3908.

Growing, Selling, and Drug Paraphernalia

Kansas provides no personal marijuana home-growing allowance. Unauthorized cultivation and distribution fall under separate criminal provisions. Quantity and circumstances affect the offense level.

Drug paraphernalia can also lead to a separate charge when used or possessed with the prohibited intent. An agricultural hemp license does not authorize growing marijuana or selling prohibited finished products.

Sources: cultivation and distribution law and paraphernalia law.

Industrial Hemp Licensing Today

Current Kansas Department of Agriculture guidance states that USDA directly regulates hemp production and requires producers to obtain a USDA license before planting. Growers should use current application instructions rather than older descriptions of Kansas’s original research or commercial licensing arrangements.

Crop licensing, processing requirements, and consumer-product restrictions address different activities. See KDA’s current industrial hemp information.

Out-of-State Purchases and Medical Cards

Buying marijuana legally in Missouri, Colorado, Oklahoma, or another jurisdiction does not authorize possession in Kansas. An out-of-state dispensary receipt or medical card does not create general Kansas possession rights.

Anyone relying on the narrow CBD treatment defense must satisfy Kansas’s own requirements, including the preparation’s composition and physician documentation. Permission granted elsewhere does not replace those conditions.

What Kansas’s Legal Changes Mean Today

Kansas has reduced some possession penalties and created CBD and hemp exceptions while retaining marijuana prohibition. It has not established recreational dispensaries or a comprehensive medical cannabis patient system.

The practical questions are specific: what substance is present, how the product is formulated, which exception applies, and whether the required documentation or license exists. Proposed legalization measures should be evaluated by their final legislative status, not their titles.

This article provides general legal information. Check current statutes and agency guidance for requirements affecting a specific situation.